Clari Vest Asset Management LLC Prothena Corp Public LTD CO Transaction History

Clari Vest Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$48.2 - $78.89 $1.38 Million - $2.27 Million	-28,733 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$21.63 - $57.65 $194 - $518	-9 Reduced 0.03%	28,733 $1.48 Million
Q1 2021 May 13, 2021	BUY	$11.0 - $28.24 $315,700 - $810,488	28,700 Added 68333.33%	28,742 $722,000
Q2 2019 Aug 16, 2019	BUY	$8.85 - $12.49 $371 - $524	42 New	42 $0

197

39.3M

601K

259K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $581M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.